- Regeneron | Pushing the Bounds of Science
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines Join our team and explore clinical trials
- Regeneron Pharmaceuticals - Wikipedia
Regeneron Pharmaceuticals Regeneron Pharmaceuticals, Inc is an American biotechnology company headquartered in Westchester County, New York The company was founded in 1988 [2]
- About Regeneron | Our Company
Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases
- Regeneron | Investigational Pipeline and Medicines in Development
Explore Regeneron’s pipeline of investigational medicines advancing through clinical trials for a range of serious diseases
- Jobs - Regeneron Careers
You choose Regeneron Submit an application to the role that best suits your skill set and career goals
- Our Approved Medicines | Regeneron
At Regeneron, our goal is to address serious medical conditions across multiple and diverse therapeutic areas Our 14 medicines approved in the U S or other countries are only the beginning of our long-term commitment to solve the human body’s most complex mysteries
- Regeneron | Research Development
Explore Regeneron’s deep expertise in genetics, biology and technology and learn about our pursuit to revolutionize medicine
- Regeneron Pharmaceuticals, Inc. (REGN) Stock Price, News, Quote . . .
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation
|